2021 Vol.2 Sept.No3 |
---|
|
![]() |
Reference: [1]Carlos I, Kenneth J R, Mary S B, et al. Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials[J].The Journal of allergy and clinical immunology,2017,139(5):1678-1680. [2]Leineweber C, Kecklund G, Orth G K. Prediction of cardiocerebrovascular and other significant disease from disturbed sleep and work strain[J]. Scandinavian journal of Work, Environment and Health,2007,33(3):215-222. [3]Boreskie K F, Kehler D S, Costa E C, et al. Standardization of the Fried frailty phenotype improves cardiovascular disease risk discrimination[J].Experimental Gerontology,2019,119(1):40-44. [4]Kyong S S, Yun K C, Young J K, et al. The effect of long working hours on cerebrovascular and cardiovascular disease; A case-crossover study[J].American journal of industrial medicine,2017,60(9):753-761. [5]Nicholas O M, Todd W R, Barry I F. APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter[J].American journal of kidney diseases : the official journal of the National Kidney Foundation,2017,70(2):281-289. [6]Lutski M, Haratz S, Weinstein G, et al. Impaired Cerebral Hemodynamics and Frailty in Patients with Cardiovascular Disease[J].The journals of gerontology.Series A. Biological sciences and medical sciences,2018,73(12):1714-1721. [7]Boreskie K F, Kehler D S, Costa E C, et al. Standardization of the Fried frailty phenotype improves cardiovascular disease risk discrimination[J].Experimental Gerontology,2019,119(1):40-44. |
Tsuruta Institute of Medical Information Technology
Address:[502,5-47-6], Tsuyama, Tsukuba, Saitama, Japan TEL:008148-28809 fax:008148-28808 Japan,Email:jpciams@hotmail.com,2019-09-16